308 related articles for article (PubMed ID: 20436884)
1. The use of isotretinoin in acne.
Layton A
Dermatoendocrinol; 2009 May; 1(3):162-9. PubMed ID: 20436884
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris.
Rao PK; Bhat RM; Nandakishore B; Dandakeri S; Martis J; Kamath GH
Indian J Dermatol; 2014 May; 59(3):316. PubMed ID: 24891681
[TBL] [Abstract][Full Text] [Related]
3. Oral isotretinoin for acne.
Costa CS; Bagatin E; Martimbianco ALC; da Silva EM; Lúcio MM; Magin P; Riera R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009435. PubMed ID: 30484286
[TBL] [Abstract][Full Text] [Related]
4. Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes.
Landis MN
Am J Clin Dermatol; 2020 Jun; 21(3):411-419. PubMed ID: 32107726
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.
Kassem B; Ismail M; Hassan F
Dermatol Ther; 2022 Dec; 35(12):e15974. PubMed ID: 36346039
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of systemic isotretinoin treatment for moderate to severe acne (insights from the real-life clinical setting).
Tolino E; Skroza N; Proietti I; Mambrin A; Balduzzi V; Marchesiello A; Maddalena P; Michelini S; Volpe S; Bernardini N; Potenza C
Dermatol Ther; 2020 Nov; 33(6):e14392. PubMed ID: 33037685
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and associated risk factors of acne relapse among Saudi acne vulgaris patients using isotretinoin.
Sa A; Y A; Am A; Sa A; L P; Na A
Saudi Pharm J; 2020 Mar; 28(3):374-379. PubMed ID: 32194340
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for optimal use of isotretinoin in acne.
Layton AM; Cunliffe WJ
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S2-7. PubMed ID: 1460120
[TBL] [Abstract][Full Text] [Related]
9. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.
Agarwal US; Besarwal RK; Bhola K
Indian J Dermatol Venereol Leprol; 2011; 77(6):688-94. PubMed ID: 22016276
[TBL] [Abstract][Full Text] [Related]
10. Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study.
De D; Kanwar AJ
Clin Drug Investig; 2011; 31(8):599-604. PubMed ID: 21591819
[TBL] [Abstract][Full Text] [Related]
11. Roaccutane treatment guidelines: results of an international survey.
Cunliffe WJ; van de Kerkhof PC; Caputo R; Cavicchini S; Cooper A; Fyrand OL; Gollnick H; Layton AM; Leyden JJ; Mascaró JM; Ortonne JP; Shalita A
Dermatology; 1997; 194(4):351-7. PubMed ID: 9252756
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fixed daily 20 mg of isotretinoin in moderate to severe scar prone acne.
Rasi A; Behrangi E; Rohaninasab M; Nahad ZM
Adv Biomed Res; 2014; 3():103. PubMed ID: 24804178
[TBL] [Abstract][Full Text] [Related]
13. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
14. Analysis of common side effects of isotretinoin.
McLane J
J Am Acad Dermatol; 2001 Nov; 45(5):S188-94. PubMed ID: 11606952
[TBL] [Abstract][Full Text] [Related]
15. Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone.
Tan BB; Lear JT; Smith AG
Clin Exp Dermatol; 1997 Jan; 22(1):26-7. PubMed ID: 9330049
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore.
Shahidullah M; Tham SN; Goh CL
Int J Dermatol; 1994 Jan; 33(1):60-3. PubMed ID: 8112947
[TBL] [Abstract][Full Text] [Related]
17. Management of severe acne.
Zouboulis CC; Bettoli V
Br J Dermatol; 2015 Jul; 172 Suppl 1():27-36. PubMed ID: 25597508
[TBL] [Abstract][Full Text] [Related]
18. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment.
Hasibur MR; Meraj Z
Mymensingh Med J; 2013 Jan; 22(1):42-8. PubMed ID: 23416807
[TBL] [Abstract][Full Text] [Related]
19. Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse.
Cakir GA; Erdogan FG; Gurler A
Int J Dermatol; 2013 Mar; 52(3):371-6. PubMed ID: 22998438
[TBL] [Abstract][Full Text] [Related]
20. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin.
Dessinioti C; Zouboulis CC; Bettoli V; Rigopoulos D
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2229-2240. PubMed ID: 32277497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
